IMT typically expresses smooth muscle markers (desmin, SMA, caldesmon, transgelin) and stromal markers (CD10, IFITM1), which can lead to misdiagnosis as leiomyoma or endometrial stromal tumor. This evidence concerns the gene CALD1 and leiomyoma.